DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(37 sites)
United States
USA06-0, Los Angeles, California USA16-0, Los Angeles, California USA01-0, Wheat Ridge, Colorado USA08-0, Florida City, Florida USA10-0, Atlanta, Georgia USA11-0, Bethesda, Maryland USA14-0, Lincoln, Nebraska USA04-0, New York, New York USA15-0, Portland, Oregon USA03-0, Charleston, South Carolina USA05-0, Virginia Beach, Virginia USA09-0, Puyallup, Washington USA07-0, Spokane, Washington Australia
AUS07-0, North Sydney, New South Wales AUS06-0, Benowa, Queensland AUS04-0, Birtinya, Queensland AUS05-0, Adelaide, South Australia China
CHN02-0, Beijing, Beijing Municipality CHN13-0, Beijing, Beijing Municipality CHN23-0, Beijing, Beijing Municipality CHN17-0, Dongguan, Guangdong CHN35-0, Shenyang, Liaoning CHN04-0, Shanghai, Shanghai Municipality CHN01-0, Shanghai, Shanghai Municipality
CHN24-0, Chengdu, Sichuan Last updated February 2026